Literature DB >> 22123098

Economics of mechanical ventilation and respiratory failure.

Colin R Cooke1.   

Abstract

For patients with acute respiratory failure, mechanical ventilation provides the most definitive life-sustaining therapy. Because of the intense resources required to care for these patients, its use accounts for considerable costs. There is great societal need to ensure that use of mechanical ventilation maximizes societal benefits while minimizing costs, and that mechanical ventilation, and ventilator support in general, is delivered in the most efficient and cost-effective manner. This review summarizes the economic aspects of mechanical ventilation and summarizes the existing literature that examines its economic impact cost effectiveness.

Entities:  

Mesh:

Year:  2012        PMID: 22123098     DOI: 10.1016/j.ccc.2011.10.004

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  10 in total

1.  Evaluating the Economic Impact of Palliative and End-of-Life Care Interventions on Intensive Care Unit Utilization and Costs from the Hospital and Healthcare System Perspective.

Authors:  Nita Khandelwal; Lyndia C Brumback; Scott D Halpern; Norma B Coe; Babette Brumback; J Randall Curtis
Journal:  J Palliat Med       Date:  2017-10-03       Impact factor: 2.947

2.  Patterns of Cost for Patients Dying in the Intensive Care Unit and Implications for Cost Savings of Palliative Care Interventions.

Authors:  Nita Khandelwal; David Benkeser; Norma B Coe; Ruth A Engelberg; Joan M Teno; J Randall Curtis
Journal:  J Palliat Med       Date:  2016-07-20       Impact factor: 2.947

3.  Adding value to mechanical ventilation.

Authors:  Guilherme Schettino
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

4.  Severe Obesity and Prolonged Postoperative Mechanical Ventilation in Elderly Vascular Surgery Patients.

Authors:  Neha Khanna; Simisola Gbadegesin; Travis Reline; Joseph D Tobias; Olubukola O Nafiu
Journal:  J Clin Med Res       Date:  2022-09-29

5.  Health Care Costs of Target Attainment for Beta-Lactam Antibiotics in Critically Ill Patients: A Retrospective Analysis of the EXPAT Study.

Authors:  Tim M J Ewoldt; Alan Abdulla; Nicole G M Hunfeld; Anouk E Muller; Diederik Gommers; Suzanne Polinder; Birgit C P Koch; Henrik Endeman
Journal:  Ther Drug Monit       Date:  2022-02-01       Impact factor: 3.118

6.  End-of-life care in the intensive care unit: can we simultaneously increase quality and reduce costs?

Authors:  J Randall Curtis; Ruth A Engelberg; Mark E Bensink; Scott D Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2012-08-02       Impact factor: 21.405

7.  Cost per QALY (quality-adjusted life year) and lifetime cost of prolonged mechanical ventilation in Taiwan.

Authors:  Mei-Chuan Hung; Hsin-Ming Lu; Likwang Chen; Ming-Shian Lin; Cheng-Ren Chen; Chong-Jen Yu; Jung-Der Wang
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

8.  Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation.

Authors:  Heidi Turunen; Stephan M Jakob; Esko Ruokonen; Kirsi-Maija Kaukonen; Toni Sarapohja; Marjo Apajasalo; Jukka Takala
Journal:  Crit Care       Date:  2015-02-19       Impact factor: 9.097

9.  Cost-effectiveness of noninvasive ventilation for chronic obstructive pulmonary disease-related respiratory failure in Indian hospitals without ICU facilities.

Authors:  Shraddha P Patel; Margarita E Pena; Charlene Irvin Babcock
Journal:  Lung India       Date:  2015 Nov-Dec

10.  A preliminary cost-effectiveness analysis of lung protective ventilation with extra corporeal carbon dioxide removal (ECCO2R) in the management of acute respiratory distress syndrome (ARDS).

Authors:  Oliver Ethgen; Jacques Goldstein; Kai Harenski; Armand Mekontso Dessap; Philippe Morimont; Michael Quintel; Alain Combes
Journal:  J Crit Care       Date:  2021-02-02       Impact factor: 3.425

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.